Have a website account?Log In orRegister for exclusive website content.
 Subscribe
Advanced Search
  • Home
  • Journal Info
    • About cco
    • Indexing and Archiving
    • Editors-in-Chief
    • Editorial Board
    • Former Editorial Board
    • Peer Review Process
    • Supplements and Series
    • Advertising Policy
  • For Authors
    • Author Instruction
    • Online Submission
    • Submit Multimedia Files
    • Reference Style
    • AME Editing Service
    • Interviews with Outstanding Authors
  • For Reviewers
    • Guidelines for Reviewers
    • Online Review
    • Reviewers
  • Ethics and Policies
    • Journal Management (Editorial Roles)
    • Editorial Policies
    • Publication Ethics Policy
    • Research Ethics Policy
    • Human and Animal Rights
    • Authorship and Contributorship
    • Informed Consent Policy
    • Conflicts of Interest
    • Data Sharing Policy
    • Open Access Statement
    • Content Licensing
    • Copyright and Permission
    • Quality Control System
    • Data and Reproducibility
    • Policy of Screening for Plagiarism Process
    • Policy of Dealing with Allegations of Research Misconduct
    • Corrections and Retractions
    • Complaints and Appeals
  • Special Contents
    • Special Series (Published)
    • Special Series (Ongoing)
    • Interviews with Guest Editors
    • Interviews with Editorial Board Members
  • Archives
  • Online First
  • Article Processing Charges
  • News
  • Home /
  • Meet The Professor /
  • Professor Charles E. Geyer: neoadjuvant therapy is becoming standard of care for HER2+ breast cancer

Professor Charles E. Geyer: neoadjuvant therapy is becoming standard of care for HER2+ breast cancer

Posted On 2016-11-28 10:33:34

Charles E. Geyer Jr., MD, FACP, is Professor of Medicine in the Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine, at the Virginia Commonwealth University School of Medicine, and he is also an Associate Director for Clinical Research at Virginia Commonwealth University Massey Cancer Center.

Read More>>

Meet The Professor

  • Douglas G. McNeel: stay current reading research literature, there is no substitute for hard work!
  • ERAS and Tubeless—Michael Haddock: the past and future of proton beam
  • Professor Norman Wolmark: perseverance sometimes pays off
  • Professor I. Craig Henderson: triple negative breast cancer is most chemo-sensitive of all subtypes of cancer
  • Professor Charles M. Balch: higher sophistication and accuracy of clean data are important for sophisticated clinical trials
  • Professor William J. Gradishar: individualized treatment scheme for breast cancer
  • Professor Charles E. Geyer: neoadjuvant therapy is becoming standard of care for HER2+ breast cancer
  • Professor Bruce D. Minsky: Advances in radiation oncology in 2014 ASTRO
  • Professor Hope S. Rugo: Reversing resistance and hormone therapy for metastatic breast cancer
  • Prof. Yi-Long Wu: Patients on the afatinib arm had a significantly better quality of life ac-cording to the data of LUX-Lung 6

About

Aims and ScopeThe Chinese Clinical Oncology (CCO; Chin Clin Oncol; Print ISSN 2304-3865; Online ISSN 2304-3873) is an Open Access, peer-reviewed, bimonthly journal (quarterly published from Sep 2012-D...

    AME Publishing Company

    • AME Case Reports
    • AME Medical Journal
    • AME Surgical Journal
    • Annals of Blood
    • Annals of Breast Surgery
    • Annals of Cancer Epidemiology
    • Annals of Cardiothoracic Surgery
    • Annals of Esophagus
    • Annals of Eye Science
    • Annals of Infection
    • Annals of Joint
    • Annals of Laparoscopic and Endoscopic Surgery
    • Annals of Lymphoma
    • Annals of Nasopharynx Cancer
    • Annals of Palliative Medicine
    • Annals of Pancreatic Cancer
    • Annals of Thyroid
    • Annals of Translational Medicine
    • Art of Surgery
    • Australian Journal of Otolaryngology
    • Biotarget
    • Cardiovascular Diagnosis and Therapy
    • Chinese Clinical Oncology
    • Current Challenges in Thoracic Surgery
    • Digestive Medicine Research
    • Frontiers of Oral and Maxillofacial Medicine
    • Gastrointestinal Stromal Tumor
    • Gland Surgery
    • Gynecology and Pelvic Medicine
    • Health Technology
    • Hepatobiliary Surgery and Nutrition
    • Journal of Emergency and Critical Care Medicine
    • Journal of Gastrointestinal Oncology
    • Journal of Hospital Management and Health Policy
    • Journal of Laboratory and Precision Medicine
    • Journal of Medical Artificial Intelligence
    • Journal of Oral and Maxillofacial Anesthesia
    • Journal of Public Health and Emergency
    • Journal of Spine Surgery
    • Journal of Thoracic Disease
    • Journal of Visualized Surgery
    • Journal of Xiangya Medicine
    • Laparoscopic Surgery
    • Longhua Chinese Medicine
    • Mediastinum
    • Mesentery and Peritoneum
    • mHealth
    • Microphysiological Systems
    • Pediatric Medicine
    • Precision Cancer Medicine
    • Pharmacogenomics Research and Personalized Medicine
    • Quantitative Imaging in Medicine and Surgery
    • Shanghai Chest
    • Therapeutic Radiology and Oncology
    • Translational Breast Cancer Research
    • Translational Andrology and Urology
    • Translational Cancer Research
    • Translational Gastroenterology and Hepatology
    • Translational Lung Cancer Research
    • Translational Pediatrics
    • Video-Assisted Thoracic Surgery
    • More Journal

All content on this site: Copyright © 2025 AME Publishing Company. All rights are reserved. For all open access content, the Creative Commons licensing terms apply.

Published by AME Publishing Company 
Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.
Email: editor@thecco.net